According to Saili Medical's announcement, Saihai Health Technology Co., Ltd., the controlling shareholder of the company, holds 21.642,500 shares of the company, accounting for 9.59% of the company's total share capital. On September 14, 2026, Saihai Technology completed the cancellation of the pledge registration of 8 million shares. On the same day, it pledged 10 million shares to Shanghai Zhangjiang Technology Microfinance Co., Ltd. to pledge financing funds to supplement working capital. After this operation, Saihai Technology pledged a total of 18 million shares of the company, accounting for 83.17% of its shareholding ratio and 7.97% of the company's total share capital. As of the disclosure date of the announcement, Saihai Technology and actual controller Wen Wei have pledged 18 million shares, accounting for 57.55% of their total shareholding ratio and 7.97% of the company's total share capital.

According to Saili Medical's announcement, Saihai Health Technology Co., Ltd., the controlling shareholder of the company, holds 21.642,500 shares of the company, accounting for 9.59% of the company's total share capital. On September 14, 2026, Saihai Technology completed the cancellation of the pledge registration of 8 million shares. On the same day, it pledged 10 million shares to Shanghai Zhangjiang Technology Microfinance Co., Ltd. to pledge financing funds to supplement working capital. After this operation, Saihai Technology pledged a total of 18 million shares of the company, accounting for 83.17% of its shareholding ratio and 7.97% of the company's total share capital. As of the disclosure date of the announcement, Saihai Technology and actual controller Wen Wei have pledged 18 million shares, accounting for 57.55% of their total shareholding ratio and 7.97% of the company's total share capital.